ArticleBrain and behavior2025
Acupuncture for Major Depressive Disorder: Exploring the Gut Microbiota as a Novel Therapeutic Pathway.
Article in Brain and behavior, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Does the Microbiota-Gut-Brain Axis Mediate the Antidepressant Effects of Acupuncture? A Structured Review of Preclinical and Clinical Evidence.Neuropsychiatric disease and treatment · 2026Review
- Imbalance of the Brain-Gut-Microbiota Axis in Major Depressive Disorder: From Pathogenesis to Clinical Translation.Neuropsychiatric disease and treatment · 2026Review
- Acupuncture for Major Depressive Disorder: Exploring the Gut Microbiota as a Novel Therapeutic Pathway.Brain and behavior · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
aimsThis study investigates the efficacy of acupuncture at Baihui (GV20) and Zusanli (ST36) acupoints in alleviating depressive symptoms and elucidates the underlying mechanisms.
methodsSixty male C57BL/6J mice were subjected to an 8-week chronic unpredictable mild stress (CUMS) paradigm. Acupuncture was administered to two groups during the final 3 weeks: one under CUMS and the other without stress. Behavioral assessments, including the sucrose preference test and tail suspension test (TST), evaluated depression-like behaviors. 16S rRNA sequencing and non-targeted metabolomics analyzed gut microbiota and metabolites, respectively, with association analysis exploring the mechanistic pathways.
resultsAcupuncture significantly ameliorated CUMS-induced depression-like behaviors, restoring sucrose preference (from a significant reduction in CUMS, p < 0.001, to an increase in CUMS + AP, p = 0.035) and reducing immobility time in the TST (p = 0.045). 16S rRNA sequencing revealed that acupuncture partially restored the CUMS-disrupted Bacteroidetes/Firmicutes ratio by specifically decreasing the pathobiont Clostridium sp. A3LF 105b and increasing beneficial bacteria such as Faecalibacterium and Lachnospiraceae UCG 001. These microbial shifts were functionally linked to the elevation of the critical metabolite sphinganine 1-phosphate (S1P). Spearman correlation analysis revealed a negative correlation between Clostridium sp. A3LF 105b and S1P (p < 0.01, R < -0.52). The modulation of gut microbiota led to increased S1P, which in turn activated the "neuroactive ligand-receptor interaction" pathway, thereby restoring neuronal activity and alleviating depressive behavior.
conclusionThe study underscores the potential of acupuncture as an antidepressant treatment, highlighting its impact on gut microbiota and metabolic pathways in alleviating depressive symptoms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.